FMS News and Press, Fresenius Medical Care AG From 10/12/23

2023-10-12 13:29:16 ET Summary Fresenius Medical Care (FMS) and Fresenius (FRE) stocks have experienced a decline due to the Novo Nordisk drug Ozempic ending a kidney failure study early. FMS remains a good player in the dialysis field and is not fundamentally impacted by the Ozem...

2023-10-12 13:24:12 ET More on Baxter, DaVita, etc. Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial? Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) DaVita: Continued Economic Hurdles, Market Expectations May Be...

2023-10-11 14:51:11 ET More on DaVita DaVita: Continued Economic Hurdles, Market Expectations May Be Correct DaVita stock sell-off over Ozempic study 'big overreaction,' says UBS DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold ...

2023-10-11 12:51:59 ET Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease. Dialysis products and services providers were broadly negative in early...

2023-10-11 12:18:08 ET Shares of Fresenius Medical Care (NYSE: FMS) were down more than 18% as of noon ET on Wednesday. The healthcare company's shares are up a little more than 5% so far this year. The drop came because a competitor's drug fared well in preventing kidney diseas...

2023-10-11 11:15:44 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Do Not Chase This Stock Over The Cliff Eli Lilly: Big Cancer Bet With Point Biopharma Global Purchase Eli Lilly POINTs Toward Radiopharmaceutical Ambitions Biggest stock movers today: Pio...

2023-10-11 09:37:37 ET Stock markets looked poised to continue their winning ways on Wednesday morning, as stock index futures were higher across the board. Investors will get a look today at the latest thought process from the Federal Reserve when it releases the minutes of its most recent...

2023-10-11 09:24:05 ET More on Baxter, DaVita, etc. Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) DaVita: Continued Economic Hurdles, Market Expectations May Be Correct Dividend Challengers Review: Baxter International DaVita ...

2023-10-11 08:28:56 ET More on Baxter, Denison Mines, etc. Denison Mines: Top Projects, Robust Balance Sheet, And Deeply Undervalued Denison Mines: A Promising Uranium Exploration Company Denison Mines: The Feasibility Study Demonstrates Wheeler's Potential D...

Capital Square Delivers 147.63% Total Return* to Investors in Medical Building DST PR Newswire KINSTON, N.C. , Oct. 11, 2023 /PRNewswire/ -- Capital Square , one of the nation's leading sponsors of tax-advantaged real estate investments and an active develope...